Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
Atacicept by Vera Therapeutics for IgA Nephropathy (Berger's Disease): Likelihood of Approval
Atacicept is under clinical development by Vera Therapeutics and currently in Phase III for IgA Nephropathy (Berger's Disease). According to...
Risk adjusted net present value: What is the current valuation of Vera Therapeutics's Atacicept?
Atacicept is a fusion protein commercialized by Vera Therapeutics, with a leading Phase III program in IgA Nephropathy (Berger's Disease)....
Risk adjusted net present value: What is the current valuation of Vera Therapeutics's Atacicept?
Atacicept is a fusion protein commercialized by Vera Therapeutics, with a leading Phase III program in IgA Nephropathy (Berger's Disease)....